ALVO Stock: Price, Earnings History and SEC Filings
Alvotech (ALVO) last traded at $4.65, down 4.91% on the latest session and down 19.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.11 against an analyst estimate of $-0.06, a miss of 83.3%.
$4.65 -4.91%
1 month-19.83%
52-week high$6.53
52-week low$2.94
Volume714,818
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ALVO earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 19, 2026 | $-0.11 | $-0.06 | -83.33% |
| Mar 2026 | May 6, 2026 | $-0.09 | $-0.07 | -28.57% |
| Dec 2025 | Mar 18, 2026 | $-0.37 | $0.13 | -384.62% |
| Sep 2025 | Nov 12, 2025 | $-0.02 | $0.05 | -140.00% |
ALVO beat the analyst EPS estimate in 0 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ALVO
SEC filing data is not available right now. You can search for ALVO on SEC EDGAR.
ALVO news
- Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026Oct 28, 2026 · finance.yahoo.com
- Repligen (RGEN) Q3 Earnings and Revenues Surpass EstimatesOct 27, 2026 · finance.yahoo.com
- New Strong Sell Stocks for October 21stOct 21, 2026 · finance.yahoo.com
- New Strong Sell Stocks for October 20thOct 21, 2026 · finance.yahoo.com
- Alvotech's Manufacturing Progress, Simponi Launch Potential Support Recovery, UBS SaysOct 20, 2026 · finance.yahoo.com
- Alvotech shares jump premarket after FDA approves new Simlandi processOct 20, 2026 · finance.yahoo.com
- Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batchOct 20, 2026 · finance.yahoo.com
About Alvotech
Alvotech (ALVO) is a US-listed public company on Nasdaq.